跳至主要内容
临床试验/IRCT20211112053042N2
IRCT20211112053042N2招募中2 期

Evaluation of efficacy and safety of morphine through nebulizer mask in the treatment of acute respiratory distress due to Covid-19 in adult patients

Karaj University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • Age 80-18 years
  • Patients with a definitive diagnosis of Covid-19 based on PCR test within 48 hours after hospitalization
  • Acute moderate respiratory distress syndrome with PaO2 / FiO2 <200 based on Berlin criteria (Force et al., 2012)
  • Patients with severe dyspnea
  • Patients in the end-stages of the disease
  • Lack of proper treatment
  • Patients with consent to participate in the project

排除标准

  • Patients with high suspicion / diagnosis of heart failure and unstable angina
  • Existence of severe shock with hemodynamic instability despite increased vascular pressure
  • Severe / undiagnosed lung infection for other reasons (chronic obstructive pulmonary disease, pulmonary fibrosis, lung cancer, bacterial pneumonia ...)
  • Diagnosis of pulmonary hemorrhage
  • Pregnancy / breastfeeding
  • An important cause other than acute respiratory distress for respiratory failure
  • Requires ECMO during the study period
  • He/she is expected to be transferred to another hospital within 72 hours
  • Known allergies to morphine
  • Sensitivity or contraindication to exogenous and endogenous opioids
  • Obesity (BMI>35 kg/m2 )
  • Patients with dissatisfaction with participating in the project

研究者

发起方
Karaj University of Medical Sciences

相似试验